In a previous analysis of our study, we found that the FDX1 high expression phenotype was associated with an activated immune phenotype in ccRCC, and previous reports have indicated that the activation of cell death could enhance the anti-tumor efficiency in tumors. This evidence concerns the gene FDX1 and nonpapillary renal cell carcinoma.